Plasma exchange for immune-related nerve diseases
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at whether removing and replacing blood plasma (called therapeutic plasma exchange or TPE) can help people with immune-related nerve or brain conditions. It includes both new and returning cases that meet standard guidelines for this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neurological (brain or nerve) condition caused by your immune system
- You are a new case or having a relapse that fits guidelines for plasma exchange
- You have no health issues that make plasma exchange unsafe, like unstable blood pressure, low calcium, or allergy to plasma or albumin
- You plan to complete at least five sessions of plasma exchange
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell-based treatment (called HY001N) for people with certain autoimmune neurological diseases that have not responded to standard treatments. The treatment aims to reset the immune system to reduce attacks and improve symptoms.
This trial tests whether plasma exchange (a procedure that cleans the blood) can help children with a severe form of autoimmune encephalitis—a condition where the immune system attacks the brain. It's for children who haven't gotten better with standard treatments like steroids or IVIG.
This study looks back at kids aged 1–18 who had a treatment called therapeutic plasma exchange (TPE) in the pediatric kidney unit. TPE is a procedure that replaces the liquid part of the blood, which may help with certain kidney conditions.
This trial tests a new plasma filter, PX2, used in a procedure called therapeutic plasma exchange (TPE) to clean harmful substances from your blood. It’s for people who already need TPE and can safely use a blood thinner during the treatment.
This study compares a blood-filtering treatment called therapeutic plasma exchange with standard medicines for people with severe autoimmune hepatitis. It aims to see if plasma exchange can improve outcomes when a liver transplant is not available soon.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
Hear when a new Neurological Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.